ECOG ACRIN EA4151
ECOG-ACRIN EA4151: Phase III Trial of Autologous Hematopoietic Cell Transplantation in MRD-Negative Patients With Mantle Cell Lymphoma in First Complete Remission

Released: December 12, 2024

Expiration: December 11, 2025

Activity

Progress
1
Course Completed